智通财经APP讯,李氏大药厂(00950)发布公告,于2025年10月15日根据在2022年5月19日采纳的购股权计划向公司若干合资格参与者(承授人)授出购股权(购股权),该等购股权可认购合共176.4万股公司普通股股份。
智通财经APP讯,李氏大药厂(00950)发布公告,于2025年10月15日根据在2022年5月19日采纳的购股权计划向公司若干合资格参与者(承授人)授出购股权(购股权),该等购股权可认购合共176.4万股公司普通股股份。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.